WuXi Biologics (Cayman) Inc 02269
News
WuXi Companies Say They're Not a Security Risk as U.S. Passes Draft of Biosecure Act — Update
WuXi Companies Reaffirm No Security Risk as U.S. House Passes Draft Biosecure Act
WuXi Shares Volatile as U.S. Bill Revised to Set Deadline for Decoupling
WuXi Shares Fall as Washington Lobbying Group Cuts Ties
WuXi Companies' Shares Fall Amid Renewed U.S. Sanction Concerns
WuXi Companies' Shares Rise on Receding Worries About Potential U.S. Sanctions
WuXi Shares Hit by U.S. Committee Seeking Inquiry, Blacklisting
U.S. Lawmakers Seek Investigation Against China's WuXi AppTec — Update
WuXi Companies' Shares Slide Amid Concerns Over Proposed U.S. Bill
WuXi AppTec Shares Continue Slide After Company Calls U.S. Draft Bill Findings Inaccurate
WuXi AppTec Says Findings of U.S. Draft Bill Against Company Aren't Accurate
WuXi Company Shares Tumble on U.S. Bill Aimed at Chinese Biotech — Update
Wuxi Biologics Shares Rise After Jump in December Projects
Wuxi Bio Selloff Extends as Analysts Cut Forecasts
Wuxi Biologics Sees Revenue Growing 10% in 2023
Wuxi Biologics Shares Slide on Lower Profit Guidance
Wuxi XDC Cayman Shares Surge on Hong Kong Debut — Update
WuXi XDC Sets IPO Price at Top of End of Range
Wuxi Biologics Unit's Hong Kong IPO Closes Order Book a Day Early, Sources Say — Update